DDX3X and neoplasm: Collectively, an inability of the death receptors to disable DDX3X activity may contribute to resistance to death receptor-induced apoptosis in tumours, suggesting that targeting DDX3X might be a useful strategy for promoting death receptor-induced apoptosis.